Provided by Tiger Trade Technology Pte. Ltd.

Allurion Technologies Inc.

0.7746
-0.0494-6.00%
Volume:121.54K
Turnover:99.45K
Market Cap:9.51M
PE:-0.10
High:0.9200
Open:0.7509
Low:0.7500
Close:0.8240
52wk High:3.45
52wk Low:0.2300
Shares:12.28M
Float Shares:6.09M
Volume Ratio:1.26
T/O Rate:2.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7600
EPS(LYR):-3.2031
ROE:--
ROA:-71.87%
PB:-0.11
PE(LYR):-0.24

Loading ...

Allurion Technologies Holdings Inc. Held Annual Shareholder Meeting

Reuters
·
Dec 20, 2025

BRIEF-Allurion Reports 23% Weight Loss, 14% Lean Mass Gain On Combining Program With Tirzepatide

Reuters
·
Nov 26, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Applied Materials, CDW,  Kohl's

Reuters
·
Nov 25, 2025

Allurion reports initial results on Allurion Program, tirzepatide combination

TIPRANKS
·
Nov 25, 2025

Allurion Reports 23% Weight Loss and Increased Lean Mass With Combined Balloon and Low-Dose Tirzepatide Therapy

Reuters
·
Nov 25, 2025

Allurion Announces Initial Results on Combining the Allurion Program With Low-Dose Tirzepatide to Optimize Muscle Mass and Glp-1 Adherence

THOMSON REUTERS
·
Nov 25, 2025

Allurion Technologies Inc - Average Weight Loss of 23% With 14% Increase in Lean Body Mass

THOMSON REUTERS
·
Nov 25, 2025

Allurion Smart Capsule Delivers Superior Weight Loss and Body Composition in New Clinical Study

Reuters
·
Nov 20, 2025

Allurion Technologies Is Maintained at Neutral by Chardan Capital

Dow Jones
·
Nov 20, 2025

Allurion Announces Strategic Distribution Partnership With Prosurg Medical In Brazil To Pioneer New Approach Focused On Metabolically Healthy Weight Loss

Reuters
·
Nov 20, 2025

Allurion Technologies Signs Distribution Partnership with ProSurg Medical in Brazil

Reuters
·
Nov 18, 2025

Allurion Technologies Inc - Partnership to Increase Access to Allurion Program With Glp-1 Therapy

THOMSON REUTERS
·
Nov 18, 2025

Allurion Technologies Delays Quarterly Financial Filing

Reuters
·
Nov 18, 2025

Allurion Technologies Q3 revenue beats expectations

Reuters
·
Nov 12, 2025

Allurion Technologies Q3 Adj. EPS $(1.18) Misses $(1.17) Estimate, Sales $2.658M Beat $2.350M Estimate

Benzinga
·
Nov 12, 2025

BRIEF-Allurion Technologies Q3 Revenue USD 2.658 Million

Reuters
·
Nov 12, 2025

Allurion Technologies Q3 Operating Expenses USD 10.934 Million

THOMSON REUTERS
·
Nov 12, 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Nov 12, 2025

Allurion Technologies provides update on Smart Capsule approval process

TIPRANKS
·
Nov 11, 2025

Allurion Technologies Raises $5 Million in Private Placement Financing

Reuters
·
Nov 11, 2025